Kanmert Daniel, Cantlon Adam, Muratore Christina R, Jin Ming, O'Malley Tiernan T, Lee Gloria, Young-Pearse Tracy L, Selkoe Dennis J, Walsh Dominic M
Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, Massachusetts 02115.
Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, Massachusetts 02115, School of Bimolecular and Biomedical Science, University College Dublin, Dublin 4, Republic of Ireland, and.
J Neurosci. 2015 Jul 29;35(30):10851-65. doi: 10.1523/JNEUROSCI.0387-15.2015.
Recent evidence suggests that tau aggregation may spread via extracellular release and subsequent uptake by synaptically connected neurons, but little is known about the processes by which tau is released or the molecular forms of extracellular tau. To gain insight into the nature of extracellular tau, we used highly sensitive ELISAs, which, when used in tandem, are capable of differentiating between full-length (FL) tau, mid-region-bearing fragments, and C-terminal (CT) fragments. We applied these assays to the systematic study of the conditioned media of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary rat cortical neurons, each of which was carefully assessed for viability. In all three neuronal models, the bulk of extracellular tau was free-floating and unaggregated and <0.2% was encapsulated in exosomes. Although most intracellular tau was FL, the majority of extracellular tau was CT truncated and appeared to be released both actively by living neurons and passively by dead cells. In contrast, only a small amount of extracellular tau was aggregation-competent tau (i.e., contained the microtubule-binding regions) and this material appears to be released solely due to a low level of cell death that occurs in all cell culture systems. Importantly, amyloid β-protein (Aβ)-induced neuronal compromise significantly increased the quantity of all forms of extracellular tau, but the presence of Aβ before detectable cell compromise did not increase extracellular tau. Collectively, these results suggest that factors that induce neuronal death are likely to be necessary to initiate the extracellular spread of tau aggregation.
Recent studies suggest that the transfer of tau between neurons underlies the characteristic spatiotemporal progression of neurofibrillary pathology. We searched for tau in the conditioned medium of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary rat cortical neurons and analyzed the material present using four different tau ELISAs. We demonstrate that the majority of tau released from healthy neurons is C-terminally truncated and lacks the microtubule-binding region (MTBR) thought necessary for self-aggregation. A small amount of MTBR-containing tau is present outside of cells, but this appears to be solely due to cell death. Therefore, if propagation of tau aggregation is mediated by extracellular tau, our findings suggest that neuronal compromise is required to facilitate this process.
最近的证据表明,tau蛋白聚集可能通过细胞外释放并随后被突触连接的神经元摄取而传播,但对于tau蛋白释放的过程或细胞外tau蛋白的分子形式知之甚少。为了深入了解细胞外tau蛋白的性质,我们使用了高度敏感的酶联免疫吸附测定(ELISA),当串联使用时,它能够区分全长(FL)tau蛋白、含中间区域的片段和C末端(CT)片段。我们将这些测定方法应用于对N2a细胞、诱导多能干细胞衍生的人类皮质神经元和原代大鼠皮质神经元的条件培养基进行系统研究,对每种细胞的活力都进行了仔细评估。在所有三种神经元模型中,大部分细胞外tau蛋白是自由漂浮且未聚集的,<0.2%被包裹在外泌体中。虽然大多数细胞内tau蛋白是全长的,但大多数细胞外tau蛋白是C末端截短的,似乎是由活神经元主动释放和死细胞被动释放的。相比之下,只有少量细胞外tau蛋白具有聚集能力(即含有微管结合区域),并且这种物质似乎仅由于所有细胞培养系统中发生的低水平细胞死亡而释放。重要的是,淀粉样β蛋白(Aβ)诱导的神经元损伤显著增加了所有形式的细胞外tau蛋白的数量,但在可检测到的细胞损伤之前存在Aβ并不会增加细胞外tau蛋白。总的来说,这些结果表明,诱导神经元死亡的因素可能是启动tau蛋白聚集细胞外传播所必需的。
最近的研究表明,神经元之间tau蛋白的转移是神经原纤维病理特征性时空进展的基础。我们在N2a细胞、诱导多能干细胞衍生的人类皮质神经元和原代大鼠皮质神经元的条件培养基中寻找tau蛋白,并使用四种不同的tau ELISA分析其中存在的物质。我们证明,从健康神经元释放的大多数tau蛋白是C末端截短的,并且缺乏自我聚集所需的微管结合区域(MTBR)。细胞外存在少量含MTBR的tau蛋白,但这似乎仅归因于细胞死亡。因此,如果tau蛋白聚集的传播是由细胞外tau蛋白介导的,我们的研究结果表明需要神经元损伤来促进这一过程。